(Q44158698)

English

Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study

scientific article published in September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study (English)

1 reference

Europe PubMed Central

30 November 2017

Judith S Hochman

13

1 reference

Europe PubMed Central

30 November 2017

Neal S. Kleiman

14

object named as

Neal S Kleiman

1 reference

Europe PubMed Central

30 November 2017

author name string

Laura S Fernandes

1

1 reference

Europe PubMed Central

30 November 2017

James E Tcheng

2

1 reference

Europe PubMed Central

30 November 2017

J Conor O'Shea

3

1 reference

Europe PubMed Central

30 November 2017

Bonnie Weiner

4

1 reference

Europe PubMed Central

30 November 2017

Todd J Lorenz

5

1 reference

Europe PubMed Central

30 November 2017

Cindy Pacchiana

6

1 reference

Europe PubMed Central

30 November 2017

Lisa G Berdan

7

1 reference

Europe PubMed Central

30 November 2017

Kelly J Maresh

8

1 reference

Europe PubMed Central

30 November 2017

Diane Joseph

9

1 reference

Europe PubMed Central

30 November 2017

Mina Madan

10

1 reference

Europe PubMed Central

30 November 2017

Tift Mann

11

1 reference

Europe PubMed Central

30 November 2017

Rakhi Kilaru

12

1 reference

Europe PubMed Central

30 November 2017

ESPRIT investigators

15

1 reference

Europe PubMed Central

30 November 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

30 November 2017

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

30 November 2017

40

1 reference

Europe PubMed Central

30 November 2017

6

1 reference

Europe PubMed Central

30 November 2017

1085-1091

1 reference

Europe PubMed Central

30 November 2017

Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Gender differences and temporal trends in clinical characteristics, stress test results and use of invasive procedures in patients undergoing evaluation for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sex-based differences in clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In-hospital cardiac mortality after acute closure after coronary angioplasty: analysis of risk factors from 8,207 procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(02)02120-4

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44158698&oldid=2107272337"